Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:968-970
doi: 10.1161/CIRCRESAHA.107.164426
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akar, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akar, F. G.
Related Collections
Right arrowRelated Article
(Circulation Research. 2007;101:968.)
© 2007 American Heart Association, Inc.


Editorials

The Perfect Storm

Defective Calcium Cycling in Insulated Fibers With Reduced Repolarization Reserve

Fadi G. Akar

From the Cardiovascular Research Center and the Department of Pharmacology and Systems Therapeutics, The Mount Sinai School of Medicine, New York.

Correspondence to Fadi G. Akar, PhD, Assistant Professor of Medicine and Pharmacology, Cardiovascular Research Center, Mount Sinai School of Medicine, New York, NY 10029. E-mail fadi.akar{at}mssm.edu



See related articles, pages 1039–1048 and 1049–1057


Key Words: catecholaminergic polymorphic ventricular tachycardia • delayed afterdepolarizations • ryanodine receptors • calcium overload • arrhythmias


*    Introduction
up arrowTop
*Introduction
down arrowCatecholaminergic Polymorphic...
down arrowCalcium-Handling Proteins in...
down arrowCAMKII Versus PKA-Mediated...
down arrowPurkinje Fibers as a...
down arrowThe Perfect Storm
down arrowReferences
 
Primary electrical diseases of the heart such as the Long QT Syndrome (LQTS), Short QT Syndrome (SQTS), Brugada Syndrome (BrS), and Catecholaminergic polymorphic ventricular tachycardia (CPVT) are inherited monogenic disorders caused by mutations in ion channel genes (ie, channelopathies), calcium handling proteins, or related molecules that occur in the absence of overt structural abnormalities.1 Because these disorders are typically associated with a high incidence of ventricular tachyarrhythmias and sudden cardiac death (SCD), they are the subject of intense investigation. Although collectively, monogenic diseases underlie a minority of SCD cases in the general population, elucidation of the underlying mechanisms by which they promote electrical instability has provided a wealth of knowledge regarding the role of ion channel dysfunction in electrical remodeling and arrhythmogenesis at multiple levels of integration, linking single amino acid mutations in ion channel genes to electrical dysfunction at the intact cell, organ, and system levels.

In recent years, numerous investigations have focused on mechanisms by which altered ion channel function and action potential properties can promote arrhythmias at the multi-cellular network level in various animal models of LQTS, SQTS, and BrS.2 In this issue of Circulation Research, Cerrone et al3 provide a strong mechanistic link between a known CPVT causing mutation and electrical instability arising from the His-Purkinje network of the intact heart in a tour de force study using high-resolution optical mapping, cellular electrophysiological measurements, a variety of pharmacological tools, and numerical simulations.


*    Catecholaminergic Polymorphic Ventricular Tachycardia
up arrowTop
up arrowIntroduction
*Catecholaminergic Polymorphic...
down arrowCalcium-Handling Proteins in...
down arrowCAMKII Versus PKA-Mediated...
down arrowPurkinje Fibers as a...
down arrowThe Perfect Storm
down arrowReferences
 
CPVT is a heritable disorder that presents clinically as exercise- or stress- induced ventricular arrhythmias, syncope, or SCD.1 Electrocardiographically, patients with CPVT exhibit polymorphic VT (PVT), bidirectional VT with an alternating QRS axis (Bi-VT), and ventricular fibrillation (VF). Several mutations in the cardiac Ryanodine Receptor (RyR2) and Calsequestrin (CSQ) have been identified in affected patients with CPVT.1 Because both RyR2 and CSQ are key calcium handling proteins involved in excitation–contraction (EC) coupling, it was postulated that abnormal intracellular calcium cycling is a determinant of CPVT-related arrhythmias.


*    Calcium-Handling Proteins in Health and Disease
up arrowTop
up arrowIntroduction
up arrowCatecholaminergic Polymorphic...
*Calcium-Handling Proteins in...
down arrowCAMKII Versus PKA-Mediated...
down arrowPurkinje Fibers as a...
down arrowThe Perfect Storm
down arrowReferences
 
EC coupling is a well-described fundamental principal by which the ionic (excitation) properties of a myocyte tightly coordinate its mechanical (contractile) function. The process is initiated by the transient opening of voltage-gated L-type calcium channels after depolarization of the cellular membrane. Calcium entry through these channels, which are strategically localized at the invaginations of the T-tubular network, in close spatial proximity to the sarcoplasmic reticulum (SR), activates a regenerative positive feedback process of calcium-induced calcium release from the SR through RyR2, resulting in tropomyosin translocation and myofilament contraction. Elevated free cytosolic calcium levels are then restored by the rapid reuptake of calcium into the SR by SERCA2a and extrusion to the extracellular space by the electrogenic sodium-calcium exchanger which generates a net depolarizing transient inward current. Disease-induced malfunction of several EC coupling proteins results in mechanical and electrical dysfunction at the cellular level that might be transduced to the entire organ to form lethal arrhythmias. Although arrhythmias that are dependent on changes in EC coupling proteins are commonly associated with structural heart disease such as heart failure or myocardial ischemia, they also occur in young, apparently healthy individuals, presumably by predisposing to delayed afterdepolarizations (DADs). In fact, DAD-induced triggered activity might constitute an important class of arrhythmias that underlie SCD in various forms of familial cardiomyopathies, including CPVT and arrhythmogenic right ventricular dysplasia (ARVD), both of which are characterized by mutations in calcium handling genes, most notably RyR2.1 At the molecular level, Wehrens et al4 elegantly demonstrated that mutant RyR2 channels found in patients with CPVT have a decreased binding affinity for FKBP12.6, a calcium regulatory protein, which normally acts to reduce the open channel probability of RyR2, thereby preserving SR calcium load during diastole. Although, at rest, the function of mutant RyR2 channels was identical to that of their wild-type counterparts, mutant channels exhibited enhanced dissociation from FKBP12.6 in response to ß-adrenergic stimulation. These authors argued that protein kinase A (PKA)-mediated phosphorylation of a single amino acid residue (Serine-2808) within RyR2 was sufficient for rendering RyR2 channels defective and enhancing the diastolic SR calcium leak, which could be effectively reversed by pharmacologically increasing the affinity of FKBP12.6 for RyR2.5


*    CAMKII Versus PKA-Mediated Phosphorylation of RyR2
up arrowTop
up arrowIntroduction
up arrowCatecholaminergic Polymorphic...
up arrowCalcium-Handling Proteins in...
*CAMKII Versus PKA-Mediated...
down arrowPurkinje Fibers as a...
down arrowThe Perfect Storm
down arrowReferences
 
The specific molecular mechanism and signaling pathways that lead to the pathological hyperphosphorylation of RyR2 have been recently challenged.6–13 For example, Chen and colleagues showed that phosphorylation of RyR2 by PKA at Ser-2808 did not dissociate FKBP12.6 from it.8 These authors subsequently identified an alternative phosphorylation site (Ser-2030), which they argued was the principal mediator of PKA phosphorylation of RyR2.7 Furthermore, Valdivia and colleagues have recently demonstrated that genetic ablation of Ser-2808 on RyR2 failed to alter the ß-adrenergic responsiveness of mice and did not modify their progression toward heart failure.6 Priori and coworkers,14 using the same mouse model studied by Cerrone et al,14 found that K201, an agent that enhances the binding of FKBP12.6 to RyR2, failed to abrogate arrhythmias induced by caffeine or epinephrine in vivo and did not prevent the generation of DADs and triggered activity in isolated cardiomyocytes, arguing against an important role for the interaction between FKBP12.6 and RyR2 in the mechanism of arrhythmias in this specific animal model of CPVT.14 More recently, Curran et al12 demonstrated that ß-adrenergic stimulation enhances diastolic SR calcium leak in a manner that is dependent on Ca2+-Calmodulin–dependent protein kinase II (CaMKII) but not PKA.

Elucidating the molecular mechanisms and signaling pathways that lead to the hyperphosphorylation of RyR2 has clear implications for the development of novel therapeutic agents.5 However, regardless of the specific molecular targets, it has become clear that enhanced diastolic calcium leak through RyR2 (either as a consequence of its dissociation from FKBP12.6 or as a result of a direct effect on RyR2 or related proteins within a larger macromolecular complex) is a major contributor to DADs in isolated cardiomyocytes. Whether or not this enhanced propensity for DADs in isolated cells directly translates to the generation and successful propagation of DADs in intact myocardium remained unclear.


*    Purkinje Fibers as a Source of DADs in CPVT
up arrowTop
up arrowIntroduction
up arrowCatecholaminergic Polymorphic...
up arrowCalcium-Handling Proteins in...
up arrowCAMKII Versus PKA-Mediated...
*Purkinje Fibers as a...
down arrowThe Perfect Storm
down arrowReferences
 
The present study by Cerrone et al3 goes a long way in demonstrating how a single amino acid substitution in RyR2 that causes DADs in isolated cardiomyocytes can also result in typical CPVT-related arrhythmias in the intact mouse heart. Remarkably, these arrhythmias were not present at baseline, but were only evoked on challenge with caffeine, isoproternol, or epinephrine which presumably uncovered the otherwise "silent" intracellular calcium instability, in a manner analogous to the "multi-hit" hypothesis.

A major contribution of the present study3 is the detailed description of the focal nature and source of CPVT-related arrhythmias, including MVT, Bi-VT, and PVT, which consistently arose from deep layers. The observation that all arrhythmias exhibited a typical epicardial breakthrough pattern that emanated from 1 (MVT) or 2 (Bi-VT and PVT) sources argues for the potential involvement of the His-Purkinje network in the mechanism of these arrhythmias. Finally, because these rhythms were extremely sensitive to pharmacological ablation of the His-Purkinje network and because they often gave rise to alternating RV and LV epicardial breakthrough patterns that could be readily converted to MVT with a wide QRS complex on administration of Lugol’s solution to the RV cavity, they most certainly originated in the His-Purkinje network and not the myocardial wall.


*    The Perfect Storm
up arrowTop
up arrowIntroduction
up arrowCatecholaminergic Polymorphic...
up arrowCalcium-Handling Proteins in...
up arrowCAMKII Versus PKA-Mediated...
up arrowPurkinje Fibers as a...
*The Perfect Storm
down arrowReferences
 
The findings of Cerrone et al3 highlight the importance of evaluating arrhythmias at the intact organ level, because the occurrence of DADs in isolated cardiomyocytes does not translate directly into sustained arrhythmias or even triggered beats in the intact heart. Moreover, this study illustrates the importance of understanding the dynamic interplay between passive and active membrane properties in the ultimate control of membrane potential, the genesis of afterdepolarizations, and the successful propagation of DADs across the myocardium (Figure). Clearly, the RyR2 mutation described here did not give rise to random ectopic foci across the ventricle that would have quickly degenerated into VF. Instead, these arrhythmias were dependent on an intact His-Purkinje network. Hence, it is clear from the present study that the threshold for DAD generation is lower in Purkinje fibers compared with intact myocardial tissue, which could be attributable to unique differences in the intrinsic ionic properties (ie, a reduced repolarizing reserve) of Purkinje compared with myocardial cells, especially in the absence of ß-adrenergic stimulation as elegantly demonstrated by Nattel and coworkers.15 Therefore, whereas ß-adrenergic stimulation enhances the propensity of calcium leak, it also increases the density of the slowly activating delayed rectifier potassium current, which might act to suppress the development of DADs. Moreover, whereas myocardial cells are tightly coupled electrically to one another, Purkinje fibers are relatively insulated from the myocardium thereby reducing the electrotonic sink that they encounter. This results in greater modulation of membrane potential by a given amount of current allowing DADs to form and propagate more readily. The specific contribution of electrotonic coupling versus intrinsic ionic properties of Purkinje fibers to DAD formation and propagation requires further investigation, especially in heart failure which reduces the repolarizing reserve of Purkinje cells16 and overall cell-to-cell coupling.17 Specifically, it will be important to evaluate whether similar mechanisms are also operative in acquired cardiac diseases that involve calcium overload, altered repolarization properties, and cell-to-cell coupling (Figure), such as in heart failure and ischemia. Finally, it will be important to investigate whether disease-induced remodeling of gap junction proteins, intra- and extracellular resistivities, and transmural fiber orientation as demonstrated in a model of hypertrophic cardiomyopathy18 increase the vulnerability to arrhythmias by lowering the threshold for DAD formation or paradoxically enhancing the ability of triggers to successfully propagate throughout the myocardium.19


Figure 1
View larger version (13K):
[in this window]
[in a new window]

 
Figure. Schematic illustrating the dynamic interplay between passive (electrotonic coupling), active (repolarization properties), and calcium handling defects in promoting delayed afterdepolarizations and CPVT-related arrhythmias.


*    Acknowledgments
 
Sources of Funding

The author was supported by NIH grant HL77180, and grants from the Fondation Leducq and Celladon Inc.

Disclosures

None.


*    Footnotes
 
The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.


*    References
up arrowTop
up arrowIntroduction
up arrowCatecholaminergic Polymorphic...
up arrowCalcium-Handling Proteins in...
up arrowCAMKII Versus PKA-Mediated...
up arrowPurkinje Fibers as a...
up arrowThe Perfect Storm
*References
 
1. Shah M, Akar FG, Tomaselli GF. Molecular basis of arrhythmias. Circulation. 2005; 112: 2517–2529.[Abstract/Free Full Text]

2. Antzelevitch C. Cardiac repolarization. The long and short of it. Europace. 2005; 7 Suppl 2: 3–9.[Free Full Text]

3. Cerrone M, Noujaim SF, Tolkacheva EG, Talkachou A, O’Connell R, Berenfeld O, Anumonwo J, Pandit SV, Vikstrom K, Napolitano C, Priori SG, Jalife J. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2007; 101: 1039–1048.[Abstract/Free Full Text]

4. Wehrens XH, Lehnart SE, Huang F, Vest JA, Reiken SR, Mohler PJ, Sun J, Guatimosim S, Song LS, Rosemblit N, D’Armiento JM, Napolitano C, Memmi M, Priori SG, Lederer WJ, Marks AR. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell. 2003; 113: 829–840.[CrossRef][Medline] [Order article via Infotrieve]

5. Lehnart SE, Terrenoire C, Reiken S, Wehrens XH, Song LS, Tillman EJ, Mancarella S, Coromilas J, Lederer WJ, Kass RS, Marks AR. Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. Proc Natl Acad Sci U S A. 2006; 103: 7906–7910.[Abstract/Free Full Text]

6. Benkusky NA, Weber CS, Scherman JA, Farrell EF, Hacker TA, John MC, Powers PA, Valdivia HH. Intact {beta}-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase a phosphorylation site in the cardiac ryanodine receptor. Circ Res. Published August 23, 2007, 10.1161/CIRCRESAHA. 107.153007.

7. Xiao B, Zhong G, Obayashi M, Yang D, Chen K, Walsh MP, Shimoni Y, Cheng H, Ter Keurs H, Chen SR. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts. Biochem J. 2006; 396: 7–16.[CrossRef][Medline] [Order article via Infotrieve]

8. Xiao B, Sutherland C, Walsh MP, Chen SR. Protein kinase A phosphorylation at serine-2808 of the cardiac Ca2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6). Circ Res. 2004; 94: 487–495.[Abstract/Free Full Text]

9. Xiao B, Jiang MT, Zhao M, Yang D, Sutherland C, Lai FA, Walsh MP, Warltier DC, Cheng H, Chen SR. Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure. Circ Res. 2005; 96: 847–855.[Abstract/Free Full Text]

10. Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res. 2005; 97: 1314–1322.[Abstract/Free Full Text]

11. Guo T, Zhang T, Mestril R, Bers DM. Ca2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes. Circ Res. 2006; 99: 398–406.[Abstract/Free Full Text]

12. Curran J, Hinton MJ, Rios E, Bers DM, Shannon TR. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res. 2007; 100: 391–398.[Abstract/Free Full Text]

13. Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S, Imbriani M, Napolitano C, Lai FA, Priori SG. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res. 2006; 99: 292–298.[Abstract/Free Full Text]

14. Cerrone M, Colombi B, Santoro M, di Barletta MR, Scelsi M, Villani L, Napolitano C, Priori SG. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res. 2005; 96: e77–e82.[Abstract/Free Full Text]

15. Han W, Wang Z, Nattel S. Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells. Am J Physiol. 2001; 280: H1075–1080.

16. Han W, Chartier D, Li D, Nattel S. Ionic remodeling of cardiac Purkinje cells by congestive heart failure. Circulation. 2001; 104: 2095–2100.[Abstract/Free Full Text]

17. Akar FG, Spragg DD, Tunin RS, Kass DA, Tomaselli GF. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res. 2004; 95: 717–725.[Abstract/Free Full Text]

18. Ripplinger CM, Li W, Hadley J, Chen J, Rothenberg F, Lombardi R, Wickline SA, Marian AJ, Efimov IR. Enhanced transmural fiber rotation and Connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res. 2007; 101: 1049–1057.[Abstract/Free Full Text]

19. Morley GE, Danik SB, Bernstein S, Sun Y, Rosner G, Gutstein DE, Fishman GI. Reduced intercellular coupling leads to paradoxical propagation across the Purkinje-ventricular junction and aberrant myocardial activation. Proc Natl Acad Sci U S A. 2005; 102: 4126–4129.[Abstract/Free Full Text]


Related Article:

Arrhythmogenic Mechanisms in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia
Marina Cerrone, Sami F. Noujaim, Elena G. Tolkacheva, Arkadzi Talkachou, Ryan O’Connell, Omer Berenfeld, Justus Anumonwo, Sandeep V. Pandit, Karen Vikstrom, Carlo Napolitano, Silvia G. Priori, and José Jalife
Circ. Res. 2007 101: 1039-1048. [Abstract] [Full Text] [PDF]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akar, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akar, F. G.
Related Collections
Right arrowRelated Article